22 June 2016
Pharma reps, we have some good news and some bad news. The good: Starting salaries in your field are among the top 10 for entry-level jobs this year. The not so good: Once again, your pay ranks lowest among U.S. medical sales folks.
According to an annual report from MedReps, pharma sales reps did have a higher base pay than some in the business--at almost $91,000, on average--but adding bonuses brought totals to a tad more than $122,000. And that’s lower than the rest of the pack.
Specialty pharma reps earned slightly more, with base pay of almost $99,000 and total compensation of $138,000. But these reps were still in the bottom third of medical salespeople overall.
But at the top of the list--again--were biotech reps. They boasted the highest base pay--almost $108,000--and average total pay topped $165,000.
Of course, it pays to be a manager: Pharma reps on the lower rungs of the ladder racked up $107,000 on average, whereas sales directors rated more than $200,000 on average. It also paid to be a man: Women earned about 12% less than men, with $119,700 in average pay.
Across the medical reps spectrum, the difference was even larger--20%--for a couple of reasons. Women were more likely to work in pharma, which we now know puts them at a pay disadvantage industrywide. They also tended to work as reps rather than as managers or sales directors, the MedReps survey found.
Meanwhile, in a separate report, pharma reps ranked 6th among the top 10 entry-level jobs, judged by compensation. With a starting salary of $55,000, sales reps came in just behind financial analysts--at $57,000--and just ahead of software developers and their $52,000 entry level salary.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
Production of finished drugs in Russia grew by 13.8%
02 May 2024